Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Future Oncology (London, England)
|
May 1, 2019
Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer
Guangjie Han, Jianfei Shi, Lili Mi, et al.
Frontiers in Oncology
|
April 1, 2026
A blood-biomarker based CTC-ALRI score predicts recurrence in hepatocellular carcinoma patients following curative resection
Jinfeng Wang, Guangjie Han, Xin Han, et al.
Current Microbiology
|
August 10, 2020
Characteristics of the sigK Deletion Mutant from Bacillus thuringiensis var. israelensis Strain Bt-59
Linghuan Xu, Guangjie Han, Xintong Fan, et al.
Mobile DNA
|
June 6, 2019
Characterization of a novel <i>Helitron</i> family in insect genomes: insights into classification, evolution and horizontal transfer
Guangjie Han, Nan Zhang, Jian Xu, et al.
BMC Gastroenterology
|
April 24, 2025
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
Jinfeng Wang, Jianfei Shi, Lili Mi, et al.
Acta Tropica
|
April 25, 2025
Screening and metabolic analysis of high-efficiency molluscicidal bacteria based on atmospheric and room temperature plasma mutagenesis
Yajing Zhu, Song Zhao, Qianghui Tang, et al.
Oncology
|
January 8, 2025
A Comparative Study on the Progression of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
Xiaoling Duan, Man Zhao, Xiaolei Yin, et al.
Bioscience Reports
|
August 9, 2020
Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A
Lili Mi, Lianhui Lei, Xiaolei Yin, et al.
Technology in Cancer Research & Treatment
|
May 10, 2023
Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
Jinfeng Wang, Man Zhao, Guangjie Han, et al.
Frontiers in Oncology
|
April 25, 2022
Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells
Man Zhao, Xiaoling Duan, Xin Han, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Future Oncology (London, England)
|
May 1, 2019
Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer
Guangjie Han, Jianfei Shi, Lili Mi, et al.
Frontiers in Oncology
|
April 1, 2026
A blood-biomarker based CTC-ALRI score predicts recurrence in hepatocellular carcinoma patients following curative resection
Jinfeng Wang, Guangjie Han, Xin Han, et al.
Current Microbiology
|
August 10, 2020
Characteristics of the sigK Deletion Mutant from Bacillus thuringiensis var. israelensis Strain Bt-59
Linghuan Xu, Guangjie Han, Xintong Fan, et al.
Mobile DNA
|
June 6, 2019
Characterization of a novel <i>Helitron</i> family in insect genomes: insights into classification, evolution and horizontal transfer
Guangjie Han, Nan Zhang, Jian Xu, et al.
BMC Gastroenterology
|
April 24, 2025
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
Jinfeng Wang, Jianfei Shi, Lili Mi, et al.
Acta Tropica
|
April 25, 2025
Screening and metabolic analysis of high-efficiency molluscicidal bacteria based on atmospheric and room temperature plasma mutagenesis
Yajing Zhu, Song Zhao, Qianghui Tang, et al.
Oncology
|
January 8, 2025
A Comparative Study on the Progression of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
Xiaoling Duan, Man Zhao, Xiaolei Yin, et al.
Bioscience Reports
|
August 9, 2020
Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A
Lili Mi, Lianhui Lei, Xiaolei Yin, et al.
Technology in Cancer Research & Treatment
|
May 10, 2023
Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
Jinfeng Wang, Man Zhao, Guangjie Han, et al.
Frontiers in Oncology
|
April 25, 2022
Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells
Man Zhao, Xiaoling Duan, Xin Han, et al.
Page
of 8